{
    "Trade/Device Name(s)": [
        "ARCHITECT iValproic Acid Immunoassay",
        "ARCHITECT iValproic Acid Calibrators (A-F)"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K090358",
    "Predicate Device Reference 510(k) Number(s)": [
        "K941615"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LEG",
        "DLJ"
    ],
    "Summary Letter Date": "August 6, 2009",
    "Summary Letter Received Date": "June 25, 2009",
    "Submission Date": "June 24, 2009",
    "Regulation Number(s)": [
        "21CFR862.3645",
        "21CFR862.3200"
    ],
    "Regulation Name(s)": [
        "Neuroleptic Drugs Radioreceptor Assay Test System",
        "Calibrator, drug specific"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Valproic acid"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT iValproic Acid Immunoassay and Calibrators for quantitative measurement of valproic acid in serum and plasma on the ARCHITECT i System",
    "Indications for Use Summary": "Quantitative measurement of valproic acid in human serum or plasma to monitor levels for appropriate therapy using the ARCHITECT i System",
    "fda_folder": "Toxicology"
}